Technology allows visually impaired to enjoy TV

Article

People with low vision can improve their ability to watch television with a new technique that allows them to enhance the contrast of images of people and objects of interest on their digital televisions.

People with low vision can improve their ability to watch television with a new technique that allows them to enhance the contrast of images of people and objects of interest on their digital televisions, according to a report in the January issue of the Journal of the Optical Society of America.

The new method, developed by the Institute's low vision expert Dr Eli Peli, involves making simple changes within the "decoders" of digital televisions, which improves the contrast enhancement. To test the technology, the research team presented eight digital videos to 24 subjects with vision impairment and six with normal vision. Each patient was given a remote control, which allowed him/her to increase or decrease the contrast of the image.

The researchers found that even subjects with normal vision selected some enhancement and that the amount of enhancement selected by those with visual impairment varied depending upon the level of contrast sensitivity loss they experienced due to their disease.

Dr Peli is now working with US firm Analog Devices Inc, to create a prototype chip that could be included in future generations of digital televisions.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.